Barhight M, Altaye M, Gist K M, Isemann B, Goldstein S L, Akinbi H
Division of Critical Care, Department of Pediatrics, University of Colorado Anschutz Medical Campus, USA.
Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, USA.
J Clin Nephrol Res. 2017;4(4). Epub 2017 Jul 22.
Preterm infants are at risk for acute kidney injury (AKI) for multiple reasons. Reports on the frequency and timeline of iatrogenic renal insults and potential consequences are limited. Our objectives are to estimate the prevalence and timing of exposure to nephrotoxic medications, and assess the association of these nephrotoxic medications with AKI in preterm infants. We performed a retrospective chart review of infants <30 weeks postmenstrual age and/or <1500 g birth weight admitted to the neonatal intensive care units at Cincinnati Children's Hospital Medical Center and University of Cincinnati Medical Center from 2011 to 2014. We queried the electronic health record for exposures to nephrotoxic medications and/or radiologic contrast media and correlated to serum creatinine concentration proximate to the exposure. Using the Kidney Disease Improving Global Outcomes (KDIGO) creatinine criteria, we assessed the AKI rate associated with the exposures. The cohort included 276 preterm infants. 233 (84%) received nephrotoxicity-associated medications. Antibiotics were the most common type (80%). AKI occurred in 9% of infants and was associated with exposure to a nephrotoxic medication. In a forward stepwise logistical regression, birth weight (OR: 0.995 (95% CI: 0.991-0.998), =0.004) and number of exposures (OR: 1.83 (95% CI: 1.33-2.53), =0.0002) were predictive of AKI. Nephrotoxic medication exposure increased the odds of AKI in preterm and low birth weight infants. Future prospective surveillance through the electronic health record in addition to routine serum creatinine monitoring may reduce the rate of exposure and subsequent AKI.
早产婴儿因多种原因面临急性肾损伤(AKI)的风险。关于医源性肾损伤的频率、时间线及潜在后果的报告有限。我们的目标是估计早产婴儿接触肾毒性药物的患病率和时间,并评估这些肾毒性药物与AKI之间的关联。我们对2011年至2014年在辛辛那提儿童医院医疗中心和辛辛那提大学医学中心新生儿重症监护病房收治的月经龄<30周和/或出生体重<1500克的婴儿进行了回顾性病历审查。我们在电子健康记录中查询了肾毒性药物和/或放射造影剂的接触情况,并将其与接触后不久的血清肌酐浓度相关联。使用改善全球肾脏病预后(KDIGO)肌酐标准,我们评估了与接触相关的AKI发生率。该队列包括276名早产婴儿。233名(84%)接受了与肾毒性相关的药物治疗。抗生素是最常见的类型(80%)。9%的婴儿发生了AKI,且与接触肾毒性药物有关。在向前逐步逻辑回归分析中,出生体重(比值比:0.995(95%置信区间:0.991 - 0.998),P = 0.004)和接触次数(比值比:1.83(95%置信区间:1.33 - 2.53),P = 0.0002)可预测AKI。肾毒性药物暴露增加了早产和低出生体重婴儿发生AKI的几率。除常规血清肌酐监测外,未来通过电子健康记录进行前瞻性监测可能会降低暴露率及随后的AKI发生率。